news
UCB receives EU approval for paediatric anti-epileptic drug
UCB has announced that the EC has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures...
List view / Grid view
Formulation
news
TLR agonists suppress tumour growth
TLR agonists injected directly into a tumour suppresses tumour growth throughout the whole body...
news
Romosozumab provides protection against fractures in osteoporosis
A new treatment for osteoporosis provides major improvements in bone density and fractures than the current standard treatment...
news
Poliovirus therapy induces immune responses against cancer
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
news
HPV vaccine associated with improved fertility
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception...
news
ALA-artemisinin combination therapy for cancer identified
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment...
news
FDA approves first biosimilar for the treatment of cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
news
FDA-approved drug may block resistance to anti-angiogenesis therapy
General study identifies targetable pathway that induces immunosuppressive environment in colorectal cancer...
news
Type 2 diabetes drug provides significant benefits to type 1 diabetic patients
A study has found that a majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels...
news
Nivolumab superior to ipilimumab for adjuvant treatment of melanoma
Adjuvant nivolumab has been found to be more superior than ipilimumab in the standard of care in patients with surgically resected stage III/IV melanoma...
news
Paul Royall joins European Pharmaceutical Review
Dr Paul Royall, Senior Lecturer in Pharmaceutics at King’s College London, and Programme Director of the MSc in Pharmaceutical Analysis and Quality Control, has joined European Pharmaceutical Review's Editorial Advisory Board.
news
Pembrolizumab shows promise in pretreated metastatic gastric cancer
Pembrolizumab has shown a promising response rate in patients with pre-treated metastatic gastric cancer, according to results from the KEYNOTE-059 trial...
news
Improved vaccine protects against nine types of HPV
Scientists have developed an improved vaccine commonly associated with cervical cancer...
news
Antidepressant could slow Parkinson’s disease
Nortriptyline, which has been used to treat depression has been found to stop the growth of abnormal proteins on the brain...
news
FDA grants orphan drug status to Cellect’s ApoGraft
The FDA has granted orphan drug designation for ApoGraft for the prevention of acute and chronic graft versus host disease...
